Rasagiline .5 mg/1 (Rasagiline TABLET) .5 mg/1

Rasagiline .5 mg tablets are a medication used to manage symptoms of Parkinson's disease. This oral treatment is designed to support motor function and may be prescribed as part of a broader therapy plan.

Strength

.5 mg/1

Pack Size

30 TABLET in 1 BOTTLE (0093-3060-56)

Manufacturer / TM Owner

Teva Pharmaceuticals USA, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rasagiline .5 mg tablets are commonly used to help manage symptoms associated with Parkinson's disease. This medication is often part of a treatment regimen aimed at improving motor function and reducing tremors. Patients may wonder, 'What is Rasagiline used for?' and the primary use is to support those with Parkinson's in maintaining daily activities.

Side Effects

Rasagiline .5 mg tablets may help improve motor function and reduce tremors in individuals with Parkinson's disease. Some users report feeling more stable and coordinated after taking this medication. As with any medication, individual experiences may vary.

Precautions & Warnings

Rasagiline .5 mg tablets should be handled with care and stored as directed. It is important to follow the guidance of a healthcare provider regarding usage and to be aware of any potential side effects. Always inform your healthcare provider of any other medications you are taking.

Avoid Interactions

Rasagiline .5 mg tablets may interact with certain foods, supplements, and other medications. It is advisable to avoid specific dietary restrictions and to consult a healthcare provider about potential interactions, especially with other Parkinson's treatments or antidepressants.

Frequently Asked Questions

Rasagiline is primarily used to manage symptoms of Parkinson's disease, such as tremors and motor function issues.

Rasagiline tablets should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Rasagiline may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Common effects of Rasagiline include improved motor function and reduced tremors in individuals with Parkinson's disease.

The safety of Rasagiline for long-term use should be discussed with a healthcare provider, as individual responses may vary.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.